About FDA
Percent of Office of Science and Engineering Laboratories (OSEL) intra- and inter-Office eConsults completed on time during the month
Dictionary: CDRH uses the internal expert consultation process to acquire information and analysis on issues related to medical devices. Intra- and inter-office consultations are completed for a variety of work products requiring expertise within and across CDRH offices, including premarket device submissions, post-approval studies, and compliance and enforcement actions. Inter-office eConsults are used to facilitate the exchange of scientific information and staff expertise across CDRH, critical to making well-supported regulatory decisions. eConsult is the system CDRH uses to manage and monitor expert consult requests.
Information is current as of December 31, 2012
Fiscal Year - 2012
| Time | Target | Percent |
|---|---|---|
| Oct 2011 | 85 | 94 |
| Nov 2011 | 85 | 93 |
| Dec 2011 | 85 | 96 |
| Jan 2012 | 85 | 95 |
| Feb 2012 | 85 | 96 |
| Mar 2012 | 85 | 95 |
| Apr 2012 | 85 | 93 |
| May 2012 | 85 | 94 |
| Jun 2012 | 85 | 93 |
| Jul 2012 | 85 | 95 |
| Aug 2012 | 85 | 97 |
| Sep 2012 | 85 | 93 |
FY 2012 Overall: 95%
Number of OSEL intra- and inter-Office eConsults completed on time during the month
Fiscal Year - 2012
| Time | Target | Number |
|---|---|---|
| Oct 2011 | N/A | 160 |
| Nov 2011 | N/A | 147 |
| Dec 2011 | N/A | 135 |
| Jan 2012 | N/A | 130 |
| Feb 2012 | N/A | 152 |
| Mar 2012 | N/A | 150 |
| Apr 2012 | N/A | 171 |
| May 2012 | N/A | 158 |
| Jun 2012 | N/A | 137 |
| Jul 2012 | N/A | 184 |
| Aug 2012 | N/A | 228 |
| Sep 2012 | N/A | 149 |
FY 2012 Total: 1,901
Total number of OSEL intra- and inter-Office eConsults completed during the month
Fiscal Year - 2012
| Time | Target | Number |
|---|---|---|
| Oct 2011 | N/A | 170 |
| Nov 2011 | N/A | 158 |
| Dec 2011 | N/A | 141 |
| Jan 2012 | N/A | 137 |
| Feb 2012 | N/A | 158 |
| Mar 2012 | N/A | 158 |
| Apr 2012 | N/A | 183 |
| May 2012 | N/A | 168 |
| Jun 2012 | N/A | 147 |
| Jul 2012 | N/A | 194 |
| Aug 2012 | N/A | 235 |
| Sep 2012 | N/A | 161 |
FY 2012 Total: 2,010
Glossary
Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.
